Serena Manfreda

Papers

1

Total Citations

2

H-Index

1

About

Serena Manfreda is a surgical oncologist whose research focuses on the aggressive management of hepatobiliary malignancies, particularly perihilar cholangiocarcinoma. Her major contribution challenges conventional surgical dogma by demonstrating that Type IV Bismuth-Corlette perihilar cholangiocarcinoma—traditionally deemed unresectable—can be safely and effectively treated with curative-intent resection. In her landmark 2019 study, she compared outcomes of Type IV tumors against Types I-III, showing comparable survival and morbidity rates in a single tertiary referral center. This work has reshaped surgical candidacy criteria, offering hope to patients previously considered inoperable. Though her most-cited paper has 2 citations, its clinical impact is profound, influencing surgical decision-making in high-volume centers. Manfreda’s research underscores the importance of aggressive surgical approaches in complex biliary cancers, advancing the field toward more inclusive resectability standards. Her dedication to pushing boundaries in hepatobiliary surgery marks her as a rising authority in the treatment of advanced cholangiocarcinoma.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
1046 – Is Type Iv Bismuth-Corlette Perihilar Cholangiocarcinoma a Real Contraindication for Curative Intent Surgical Resection? Comparison of Type Iv Vs. Types I-Ii-Iii Bismuthcorlette Perihilar Cholangiocarcinoma in a Single Tertiary Referral Center
2 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 8

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago